Evidence map›Paper›PMID 33937290›Full record

ArticleFrontiers in medicine2021

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.

Alvaro Gomez, Victor Qiu, Arvid Cederlund, Alexander Borg, Julius Lindblom, Sharzad Emamikia, Yvonne Enman, Jon Lampa, Ioannis Parodis

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lessons Learnt from the Belimumab Trials in Systemic Lupus Erythematosus.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alvaro GomezDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Victor QiuDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Arvid CederlundDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Alexander BorgDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Julius LindblomDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Sharzad EmamikiaDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Yvonne EnmanDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Jon LampaDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Ioannis ParodisDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biologic drugsfatiguehealth-related quality of lifepatient perscpectivepatient-reported outcomesystemic lupus erythematosus

Identifiers

PMID33937290
PMCPMC8085308
OpenAlexW3155171837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.